Linghui Zhou

7.3k citations

69 papers · 2.6k indexed · 1 hit paper · h-index 29

Impact in

Oncology top 5%
- Global Cancer Incidence and Screening
- CAR-T cell therapy research
- Cancer Risks and Factors
Cancer Research top 5%
- Cancer-related molecular mechanisms research

Papers in

Oncology 31
- CAR-T cell therapy research 12
- Global Cancer Incidence and Screening 8
- Cancer Risks and Factors 7
Cancer Research 16
- Cancer-related molecular mechanisms research 9

Co-authors: Zhijun Dai Yujiao Deng Zhen ZhaiNa LiYi Zheng Qian Hao Dingli Song Peng Xu
Journals: Aging (5 papers)Frontiers in Oncology (5 papers)Journal of Hematology & Oncology (4 papers)JAMA Network Open (3 papers)Cancer Medicine (3 papers)
Partner nations: China United States Switzerland

In The Last Decade

Linghui Zhou

67 papers receiving 2.6k citations

Hit Papers

align trajectories log scale

Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017 2019 · 267 citations

Peers

Countries citing papers authored by Linghui Zhou

Since Specialization

Citations

This map shows the geographic impact of Linghui Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linghui Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linghui Zhou more than expected).

Fields of papers citing papers by Linghui Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linghui Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linghui Zhou. The network helps show where Linghui Zhou may publish in the future.

Co-authors

The 25 scholars most cited alongside Linghui Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Linghui Zhou Line = papers co-authored together Linghui Zhou links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	OriCAR-017, a novel GPRC5D-targeting CAR-T, in patients with relapsed/refractory multiple myeloma: Long term follow-up results of phase 1 study (POLARIS). Journal of Clinical Oncology ·He Huang, Yongxian Hu, A. Schouteet, Guoqing Wei, Linghui Zhou, Shan Fu, Quizzi Để, Ruimin Hong, Jiazhen Cui, Shelby Stricker, Yu. S. Karchevsky, Elizabeth Boosahda, ro Russo Michele Bianchi Silvia Panseri Monica S, Sharmeen Islam, Yanni Zhang, 石田良一, Шкребнёва Ирина Ивановна	2024	7
2	Light efficacy estimation for fruit trees based on LIDAR point clouds: A case study on pear trees Scientia Horticulturae ·Yassine Akrim, رقیه شنبه ای, Helmut Schaller, Shenghui Yang, Zohreh Mohammadi Shad, Linghui Zhou, Yaxiong Wang, Feng Kang, 南飞雁, Yongjun Zheng	2023	3
3	GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial The Lancet Haematology ·Mingming Zhang, Guoqing Wei, Linghui Zhou, Yu. S. Karchevsky, Rosa Pablos de la Rosa, Wei Zhang, Dongrui Wang, Lusia Vreyda Adveni, Jiazhen Cui, Shelby Stricker, Shan Fu, Xinkai Zhou, Elizabeth Boosahda, ro Russo Michele Bianchi Silvia Panseri Monica S, エルチンサレンゴウワ, Шкребнёва Ирина Ивановна, Yongxian Hu, He Huang	2023	91
4	Effect of intra-knee injection of autologous adipose stem cells or mesenchymal vascular components on short-term outcomes in patients with knee osteoarthritis: an updated meta-analysis of randomized controlled trials Arthritis Research & Therapy ·Jim Vine, Jessica Brimble, Jiangbo Yan, Zhiqun Tang, Linghui Zhou, Željko Vukić, Ba Xuejie	2023	14
5	Succinate and mitochondrial DNA trigger atopic march from atopic dermatitis to intestinal inflammation Journal of Allergy and Clinical Immunology ·Shan Wang, Bowen Liu, Jiahao Huang, HU An-yuan, Linghui Zhou, Ying He, Jie Yan, Ailin Tao	2022	15
6	CAR T-cell therapies in China: rapid evolution and a bright future The Lancet Haematology ·Yongxian Hu, Quizzi Để, Tianning Gu, Linqin Wang, Yiyun Wang, Linghui Zhou, Ruimin Hong, Troy Ballesteros, Mingming Zhang, Peihua Lu, He Huang	2022	32
7	Cytokine profiles are associated with prolonged hematologic toxicities after B-cell maturation antigen targeted chimeric antigen receptor–T-cell therapy Cytotherapy ·Linqin Wang, Ruimin Hong, Linghui Zhou, Yiyun Wang, A. Jensen, Fang Ni, Mingming Zhang, Houli Zhao, Slaven Brumec, Alex H. Chang, Huijun Xu, Yongxian Hu, Guoqing Wei, He Huang	2022	6
8	Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma Cancer Immunology Immunotherapy ·Ming Yi, Anping Li, Linghui Zhou, Qian Chu, Suxia Luo, Kongming Wu	2021	96
9	Trends of the incidence of drug use disorders from 1990 to 2017: an analysis based on the Global Burden of Disease 2017 data Epidemiology and Psychiatric Sciences ·Zhenyu Pan, Jun Zhang, Hua Cheng, ยอดสวรรค์ อิกูจิ, Na Li, Yujiao Deng, Linghui Zhou, Zhijun Dai, Jun Lyu	2020	27
10	Associations of lncRNA H19 Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis Molecular Therapy — Nucleic Acids ·Yujiao Deng, Linghui Zhou, Jia Yao, Yu Liu, Yi Zheng, Si Yang, Ying Wu, Na Li, Peng Xu, Lijuan Lyu, Dai Zhang, Jun Lyu, Zhijun Dai	2020	28
11	Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study Journal of Hematology & Oncology ·Yujiao Deng, Peng Zhao, Linghui Zhou, Dong Xiang, J. W. Roberts, Yu Liu, Jian Ruan, Xianghua Ye, Yi Zheng, Jia Yao, Zhen Zhai, Shuqian Wang, Si Yang, Ying Wu, Na Li, Peng Xu, Dai Zhang, Huafeng Kang, Jun Lyu, Zhijun Dai	2020	167
12	Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study Aging ·Yujiao Deng, Meng Wang, Linghui Zhou, Yi Zheng, Na Li, Tian Tian, Zhen Zhai, Si Yang, Qian Hao, Ying Wu, Dingli Song, Dai Zhang, Jun Lyu, Zhijun Dai	2020	59
13	GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis Molecular Therapy — Nucleic Acids ·Linghui Zhou, Shan‐Shan Dong, Yujiao Deng, Pengtao Yang, Yi Zheng, Yao Li, Masahiko Araseki, Assel Nurmanova, Ying Wu, Zhen Zhai, Na Li, Huafeng Kang, Zhijun Dai	2019	13
14	Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study Journal of Hematology & Oncology ·Linghui Zhou, Yujiao Deng, Na Li, Yi Zheng, Tian Tian, Zhen Zhai, Si Yang, Qian Hao, Ying Wu, Dingli Song, Dai Zhang, Jun Lyu, Zhijun Dai	2019	83
15	<p>Association Between Genetic Polymorphisms In <em>TYMS </em>And Glioma Risk In Chinese Patients: A Case-Control Study</p> OncoTargets and Therapy ·Yao Li, Linghui Zhou, Yujiao Deng, Yi Zheng, Pengtao Yang, Meng Wang, Raul Bocangel Alvarez, Qian Hao, Peng Xu, Na Li, Ying Wu, Zhen Zhai, Lijuan Lyu, Zhijun Dai	2019	6
16	Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women Cancer Cell International ·Zhijun Dai, Tian Tian, Meng Wang, Tie‐Lin Yang, Hongtao Li, Shuai Lin, Qian Hao, Peng Xu, Yujiao Deng, Linghui Zhou, Na Li, Yan Diao	2019	16
17	Effects of Postoperative Radiotherapy in Early Breast Cancer Patients Older than 75 Years: A Propensity-Matched Analysis Journal of Cancer ·Linghui Zhou, Pengtao Yang, Yi Zheng, Tian Tian, Cong Dai, Meng Wang, Shuai Lin, Yujiao Deng, Qian Hao, Zhen Zhai, Hongtao Li, Zhijun Dai	2019	2
18	GSTM1 and GSTT1 null genotype increase the risk of hepatocellular carcinoma: evidence based on 46 studies Cancer Cell International ·Kristen Keana Ritchie, Feng Xue, Yi Zheng, Pengtao Yang, Shuai Lin, Yujiao Deng, Peng Xu, Linghui Zhou, Qian Hao, Zhen Zhai, Ying Wu, Zhijun Dai, Shu Chen	2019	22
19	Associations of interleukin-6 gene polymorphisms with cancer risk: Evidence based on 49,408 cancer cases and 61,790 controls Gene ·Linghui Zhou, Yi Zheng, Tian Tian, Kang Liu, Meng Wang, Shuai Lin, Yujiao Deng, Cong Dai, Peng Xu, Qian Hao, Huafeng Kang, Zhijun Dai	2018	26
20	MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma European Journal of Surgical Oncology ·W. Wang, Hui Lin, Linghui Zhou, Qianqian Zhu, Shuyang Gao, Haiyang Xie, Xiujuan Sun, Zhifei Xu, Jianfeng Wei, Xinhui Huang, Shusen Zheng	2013	72

About Linghui Zhou

Linghui Zhou is a scholar working on Oncology, Cancer Research, Nephrology, Hematology and Pulmonary and Respiratory Medicine, having authored 69 papers that have together received 2.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (12 papers), Cancer-related molecular mechanisms research (9 papers), Global Cancer Incidence and Screening (8 papers), Cancer Risks and Factors (7 papers), Virus-based gene therapy research (5 papers), Circular RNAs in diseases (5 papers), DNA Repair Mechanisms (4 papers) and Multiple Myeloma Research and Treatments (4 papers). The work is most often cited by research in Oncology (976 citations), Cancer Research (502 citations), Hematology (270 citations), Pulmonary and Respiratory Medicine (433 citations) and Health, Toxicology and Mutagenesis (170 citations). Linghui Zhou has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Zhijun Dai, Yujiao Deng, Zhen Zhai, Na Li, Yi Zheng, Qian Hao, Dingli Song, Peng Xu, Si Yang and Ying Wu. Their work appears in journals such as Aging, Frontiers in Oncology, Journal of Hematology & Oncology, JAMA Network Open and Cancer Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact